Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cytokinetics Inc (CYTK) vs Icl Group Ltd (ICL) Price & Performance

Cytokinetics IncTrade
Icl Group LtdTrade

Price performance (Past 24H)

Key statistics

Cytokinetics Inc vs Icl Group Ltd — how do they compare? Cytokinetics Inc trades at $76.61 (market cap $10.63B), while Icl Group Ltd trades at $5.45 (market cap $6.94B). The key difference: Cytokinetics Inc is the larger of the two by market cap, and Icl Group Ltd pays a 3.86% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.

CYTKICL
Market Cap
$10.63B$6.94B
Sector
TechnologyBasic Materials
52-Week High
$87.26$6.84
52-Week Low
$34.31$4.80
Enterprise Value
$10.74B$9.58B
Dividend Yield
3.86%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cytokinetics Inc

No Aura AI signal available yet.

Icl Group Ltd

ICL trades at $5.34, up 0.56% today, with a bullish technical signal supported by moving averages. Recent Q2 2026 earnings beat expectations with EPS of $0.12 versus $0.11 expected, continuing a trend of positive surprises. The company maintains stable cash flow from operations around $1.1B annually and pays consistent dividends, with recent payments of $0.05 and $0.06 per share.

Outlook remains cautious with 100% analyst hold ratings citing fair valuation. Risks include declining profit margins (3.95% net margin in 2025) and exposure to commodity price volatility. The stock offers moderate value with P/E of 22.25 and P/S of 0.89, but requires monitoring of cost transformation program effectiveness amid raw material inflation.

Returns comparison

Trailing returns across standard periods

About Cytokinetics Inc

Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.

Read more on CYTK

About Icl Group Ltd

ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and innovative agriculture solutions (IAS). These segments all contribute to the company's development of agriculture, food, and engineered material products and services. The company mines and manufactures potash and phosphates to be used as ingredients in fertilizers and serve as a component in the pharmaceutical and food additives industries. It is also engaged in industrial additives and materials, including flame retardants, phosphate salts, specialty phosphate blends, purified phosphoric acid, electronic-grade specialty phosphoric acids. Its geographical segments are Europe, Asia, North & South America, and the Rest of the world.

Read more on ICL